Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Lung Cancer

  Free Subscription


23.09.2019

1 Am J Ind Med
1 Am J Respir Crit Care Med
1 Ann Oncol
2 Ann Thorac Surg
1 Br J Cancer
1 Cancer
1 Cancer Chemother Pharmacol
1 Eur Respir J
1 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
1 JAMA Oncol
1 Lung Cancer
1 Oncogene
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Ind Med

  1. LOEWEN G, Black B, Henschke C, Yankelevitz D, et al
    Lung cancer screening in patients with Libby amphibole disease.
    Am J Ind Med. 2019 Sep 18. doi: 10.1002/ajim.23042.
    PubMed     Text format     Abstract available


    Am J Respir Crit Care Med

  2. HARBER P
    Asbestos, Pleural Plaques, and Lung Cancer: Untangling the Relationships.
    Am J Respir Crit Care Med. 2019 Sep 20. doi: 10.1164/rccm.201908-1676.
    PubMed     Text format    


    Ann Oncol

  3. DE VRIES R, Muller M, van der Noort V, Theelen WSME, et al
    Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath.
    Ann Oncol. 2019 Sep 17. pii: 5567488. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  4. SHEWALE JB, Correa AM, Brown EL, Leon Novelo LG, et al
    Time Trends of Perioperative Outcomes in Early-Stage Non-Small Cell Lung Cancer Resection Patients.
    Ann Thorac Surg. 2019 Sep 17. pii: S0003-4975(19)31400.
    PubMed     Text format     Abstract available

  5. ZANG R, Shi JF, Lerut TE, Wang L, et al
    Ten-Year Trends of Clinicopathologic Features and Surgical Treatment of Lung Cancer in China.
    Ann Thorac Surg. 2019 Sep 14. pii: S0003-4975(19)31393.
    PubMed     Text format     Abstract available


    Br J Cancer

  6. SCHREIBER LM, Urbiola C, Das K, Spiesschaert B, et al
    The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer.
    Br J Cancer. 2019 Sep 18. pii: 10.1038/s41416-019-0574.
    PubMed     Text format     Abstract available


    Cancer

  7. AHVENAINEN TV, Makinen NM, von Nandelstadh P, Vahteristo MEA, et al
    Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31754.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  8. UEMURA T, Oguri T, Maeno K, Sone K, et al
    ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer.
    Cancer Chemother Pharmacol. 2019 Sep 17. pii: 10.1007/s00280-019-03959.
    PubMed     Text format     Abstract available


    Eur Respir J

  9. SPIRO SG, Shah PL, Rintoul RC, George J, et al
    Sequential screening for lung cancer in a high-risk group: randomised controlled trial.
    Eur Respir J. 2019 Sep 19. pii: 13993003.00581-2019.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  10. YAMAMOTO M, Aiyama H, Koiso T, Watanabe S, et al
    Validity of a Recently-Proposed Prognostic Grading Index, Brain Metastasis Velocity, for Brain Metastasis Patients Undergoing Multiple Radiosurgical Procedures.
    Int J Radiat Oncol Biol Phys. 2018 Nov 2. pii: S0360-3016(18)33925.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  11. MIHAJLOVIC J, Diehl LAM, Hochhaus A, Clement JH, et al
    Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells.
    J Cancer Res Clin Oncol. 2019 Sep 17. pii: 10.1007/s00432-019-03026.
    PubMed     Text format     Abstract available


    JAMA Oncol

  12. SULLIVAN DR, Chan B, Lapidus JA, Ganzini L, et al
    Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health Administration.
    JAMA Oncol. 2019 Sep 19. pii: 2751526. doi: 10.1001/jamaoncol.2019.3105.
    PubMed     Text format     Abstract available


    Lung Cancer

  13. GALLI G, De Toma A, Pagani F, Randon G, et al
    Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
    Lung Cancer. 2019;137:38-42.
    PubMed     Text format     Abstract available


    Oncogene

  14. ESTEVES P, Dard L, Brillac A, Hubert C, et al
    Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F.
    Oncogene. 2019 Sep 16. pii: 10.1038/s41388-019-1009.
    PubMed     Text format     Abstract available


    PLoS One

  15. BANSAL M, He J, Peyton M, Kustagi M, et al
    Elucidating synergistic dependencies in lung adenocarcinoma by proteome-wide signaling-network analysis.
    PLoS One. 2019;14:e0208646.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: